Clinical Trials Sponsored by Minneapolis Heart Institute Foundation

Total 321 results

Minneapolis Heart Institute Foundation
Minneapolis Heart Institute; Twin Cities Heart Foundation

Terminated

Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis (RADAR)

Aortic Valve Stenosis

United States
Minneapolis Heart Institute Foundation

Recruiting

Progress Complication

Coronary Artery Disease

United States
Minneapolis Heart Institute Foundation

Recruiting

Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography (GE OCT)

Coronary Artery Disease | Contrast Media Reaction

United States
Minneapolis Heart Institute Foundation

Completed

Deactivation of Implantable Cardioverter Defibrillator During Non-thoracic Surgical Procedures (Dinosur)

Implantable Cardioverter-Defibrillators

United States
Minneapolis Heart Institute Foundation

Completed

Endovascular Aneurysm Repair (EVAR) Gate Study (EVAR)

Abdominal Aortic Aneurysm (AAA)

United States
Minneapolis Heart Institute Foundation

Recruiting

Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

Heart Attack | Enlarged Heart

United States
Minneapolis Heart Institute Foundation

Recruiting

Progress Bifurcation Global Registry

Coronary Artery Disease | Coronary Bifurcation Lesions

United States
Minneapolis Heart Institute Foundation

Recruiting

Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS-CTO)

Coronary Artery Disease

United States, Canada, Egypt, Greece, Lebanon, Russian Federation
Minneapolis Heart Institute Foundation

Active, not recruiting

The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial (DESIFOR)

Cardiovascular Diseases | Cardiovascular Risk Factor | Adverse Effect

United States
Minneapolis Heart Institute Foundation

Not yet recruiting

Impact of CTO PCI (Chronic Total Occlusion Percutaneous Intervention) on Regular Physical Activity

Chronic Total Occlusion | Occlusion

United States
Minneapolis Heart Institute Foundation

Recruiting

Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions

Percutaneous Coronary Intervention | Target Vessel Failure in Saphenous Vein Grafts

United States
Minneapolis Heart Institute Foundation

Recruiting

Racial and Economic Disparities and Unmet Needs in Patients With Severe Aortic Valvular Disease

Aortic Valve Stenosis | Disparities in Treatment of Aortic Valve Stenosis

United States
Minneapolis Heart Institute Foundation

Recruiting

Radial vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH) (REBIRTH)

Patient Satisfaction | Vascular Access Complication

United States
Minneapolis Heart Institute Foundation

Withdrawn

The SHINE-CTO Trial (SHINE-CTO)

Coronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Percutaneous Transluminal Coronary Angioplasty
Minneapolis Heart Institute Foundation
Regeneron Pharmaceuticals

Terminated

The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot Trial (ASAP-SVG)

Saphenous Vein Graft Atherosclerosis

United States
Minneapolis Heart Institute Foundation
Forest Laboratories

Terminated

Alternative in Beta Blocker Intolerance: The ABBI Trial (ABBI)

Coronary Artery Disease

United States
Minneapolis Heart Institute Foundation
Boston Scientific Corporation

Completed

Coronary Artery Disease (CAD) in Women Marathon Runners

Coronary Artery Disease

United States
Jesse Manunga, MD
Minneapolis Heart Institute Foundation

Not yet recruiting

Safety and Effectiveness of Surgeon-Modified Stent Grafts forTreatment of Complex Aortic Aneurysms (Assets)

Aortic Aneurysm | Thoracoabdominal Aneurysm | Juxtarenal Aortic Aneurysm | Pararenal Aneurysm | Failed Previous Infrarenal Repairs (Failed EVAR)

United States
Minneapolis Heart Institute Foundation
Osprey Medical, Inc

Terminated

REduction of Contrast Via DyeVert Used in CTO Procedures (REDUCe)

Chronic Total Occlusion of Coronary Artery

United States
Minneapolis Heart Institute Foundation
Baxter Healthcare Corporation

Completed

Quality of Life in Patients With Refractory Angina

Refractory Ischemia

United States
Minneapolis Heart Institute Foundation
Allina Health System

Completed

Bone Marrow Stem Cell Infusion Following a Heart Attack

Acute Myocardial Infarction

United States
Allina Health System
Minneapolis Heart Institute Foundation

Recruiting

Effects of CRT Optimization as Assessed by Cardiac MR

Heart Failure, Systolic

United States
Minneapolis Heart Institute Foundation
Abbott Medical Devices

Completed

Corticosteroid Pulse After Ablation (SAAB)

Atrial Fibrillation

United States
Minneapolis Heart Institute Foundation
The Medicines Company

Completed

Single Center Registry of Non-STEMI Acute Coronary Syndrome Patients Treated With Bivalirudin

Non-STEMI Acute Coronary Syndrome

United States
Minneapolis Heart Institute Foundation
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI)

Acute Myocardial Infarction

United States
Minneapolis Heart Institute Foundation
Academy of Nutrition and Dietetics

Completed

diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED) (ENHANCED)

Diabetes Mellitus, Type 2
Minneapolis Heart Institute Foundation
Society for Cardiovascular Angiography and Interventions

Completed

Post-conditioning to Reduce Infarct Size

Myocardial Infarction

United States
University of Minnesota
National Heart, Lung, and Blood Institute (NHLBI); Allina Health System; Minneapolis...

Completed

New Ulm at HOME (Healthy Offerings Via the Mealtime Environment), NU-HOME (NU-HOME)

Physical Activity | Obesity, Childhood | Food Intake | Rural Health

United States
Hennepin Healthcare Research Institute
National Heart, Lung, and Blood Institute (NHLBI); The Miriam Hospital; University... and other collaborators

Active, not recruiting

Post Acute Cardiac Event Smoking (PACES) Study

Tobacco Use | Acute Coronary Syndrome

United States
Massachusetts General Hospital
Medtronic; Minneapolis Heart Institute; Catholic Medical Center

Recruiting

The HALT Biomarker Study (HALT)

Aortic Stenosis | Hypo-attenuated Leaflet Thickening | Bioprosthetic Valve Degeneration

United States
German Heart Institute
The German Heart Foundation

Unknown

Comparison of Different Frailty Assessment Tools

Heart Failure

Germany
Baker Heart Research Institute
National Heart Foundation, Australia

Unknown

Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome Obesity

Metabolic Syndrome

Australia
HeartFlow, Inc.
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Baim Institute for Clinical Research and other collaborators

Completed

Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography (DeFACTO)

Coronary Artery Disease

United States
Lithuanian University of Health Sciences
Baylor Scott and White Health; Minneapolis Heart Institute

Completed

Impact of Intracoronary Versus Intravenous Epinephrine Administration During Cardiac Arrest . ((iCPR))

Cardiopulmonary Arrest | Epinephrine Causing Adverse Effects in Therapeutic Use

Lithuania
Karolinska Institutet
Swedish Heart Lung Foundation

Completed

The Effects of Heated Tobacco Products Use on Lung Function and Volatile Organic Compounds in Exhaled Air

Lung Inflammation

Sweden
Karolinska Institutet
Swedish Heart Lung Foundation

Completed

Compression Only-CPR Versus Standard-CPR (TANGO2)

Cardiac Arrest | Out of Hospital Cardiac Arrest

Sweden
Karolinska Institutet
Swedish Heart Lung Foundation

Unknown

Follow-up of Sollentuna Prevention Program (SoPP)

Cardiovascular Diseases
Lithuanian University of Health Sciences
Klaipėda University; Minneapolis Heart Institute; Kreiskrankenhaus Rotenburg...

Recruiting

Patient Autonomy and Statin Therapy Adherence (PASTA)

Drug Adherence

Lithuania
National Heart and Lung Institute
Royal Brompton & Harefield NHS Foundation Trust; British Heart Foundation

Completed

Cardiac Rehabilitation for the Treatment of Refractory Angina

Coronary Disease | Angina Pectoris

United Kingdom
Kansas City Heart Rhythm Research Foundation
Kansas City Heart Rhythm Institute

Not yet recruiting

Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry (MAVERIC)

Myocarditis | Ventricular Tachycardia (VT) | Premature Ventricular Contractions

United States
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Evaluation of a Web-based Intervention to Promote Physical Activity in Patients With Heart Disease.

Coronary Artery Disease (CAD)

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation (STEP)

Smoking Cessation

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension (RVMET)

Pulmonary Arterial Hypertension

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling (RW)

Smoking Cessation | Psychiatric Illness

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Interactive Voice Response Telephone Technology for the Treatment of Smoking in Patients With Heart Disease (IVR)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease

Cerebrovascular Disorders | Smoking Cessation

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Canada

Completed

Family Heart Health Program: Randomized, Controlled Trial (FHHP-RCT)

Coronary Heart Disease

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

CPAP Therapy in Patients With Heart Failure and Obstructive Sleep Apnea. (PET-OSA)

Heart Failure | Obstructive Sleep Apnea

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease

Coronary Heart Disease

Canada
Kansas City Heart Rhythm Research Foundation
Kansas City Heart Rhythm Institute

Not yet recruiting

Impact of Steerable Delivery Sheaths on Successful Closure of LA A With AMULET

Stroke | Atrial Fibrillation

United States

Clinical Trials Sponsored by Minneapolis Heart Institute Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations